GWW vs TRDA · P/E 27, rev $9.76B vs P/E 12, rev $1.8M
WW Grainger Inc (GWW) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the GWW and TRDA stock pages for the full models.
Not investment advice.